Transaction · 0001865210-26-000002

Ndu Adora

Ndu Adora, DIR, reported a transaction classified as exercise at ACADIA PHARMACEUTICALS INC involving 8107.000000 shares. Reported holdings after the transaction were 32908.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MDIR
ACADACADIA PHARMACEUTICALS INC
Trade date
May 29, 2026
Filing date
Jun 01, 2026
View on SEC Insider profile
Disclosed valueUnknownShares × reported price
Shares traded8.10kPrice unknown
Holdings after32.9kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

ACAD price since this filing

Daily closing prices, with the filing date and available return windows
ACAD · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.2%1w ago -2.0%1d ago +0.5%
Returns since7d +0.8%30d +17.1%90d +35.3%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001865210-26-000002
Common Stock
Transaction date
May 29, 2026
Filed Jun 01, 2026, 10:00 PM · 3d delay
Shares
8,107 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
32,908 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

-2 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

  2. F2

    The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held.

  3. F3

    The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next…

  4. F4

    The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.

Original filing · 0001865210-26-000002
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ACAD